An Early Phase 1 interventional study of CivaDerm in Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin, sponsored by CivaTech Oncology. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-24.
Sponsored by CivaTech Oncology · Early Phase 1, Interventional, and Treatment
This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.
364 studies on the registry are indexed under Carcinoma, Basal Cell; 66 are open to participants now.
This study's enrollment of 10 is below the median of 41 across 258 interventional studies indexed under Carcinoma, Basal Cell.
Browse Carcinoma, Basal Cell studies →CivaTech Oncology is the lead sponsor of 5 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Radioactive bandage applied to surface of the body worn for approximately one week.
Device: CivaDerm
radioactive bandage
skin toxicity events
grade 3+ events
Time frame: within 2 months of treatment
dose delivered to target
calculated radiation dose
Time frame: 1 week
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
CivaTech Oncology